VitaSpring Biomedical Pink Sheet Forward View
| VSBC Stock | USD 1.00 0.00 0.00% |
VitaSpring Pink Sheet outlook is based on your current time horizon. Investors can use this forecasting interface to forecast VitaSpring Biomedical stock prices and determine the direction of VitaSpring Biomedical Co's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of VitaSpring Biomedical's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of VitaSpring Biomedical's share price is below 20 . This entails that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using VitaSpring Biomedical hype-based prediction, you can estimate the value of VitaSpring Biomedical Co from the perspective of VitaSpring Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of VitaSpring Biomedical Co on the next trading day is expected to be 1.00 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. VitaSpring Biomedical after-hype prediction price | USD 1.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
VitaSpring |
VitaSpring Biomedical Additional Predictive Modules
Most predictive techniques to examine VitaSpring price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VitaSpring using various technical indicators. When you analyze VitaSpring charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
VitaSpring Biomedical Naive Prediction Price Forecast For the 4th of February
Given 90 days horizon, the Naive Prediction forecasted value of VitaSpring Biomedical Co on the next trading day is expected to be 1.00 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict VitaSpring Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that VitaSpring Biomedical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
VitaSpring Biomedical Pink Sheet Forecast Pattern
| Backtest VitaSpring Biomedical | VitaSpring Biomedical Price Prediction | Research Analysis |
VitaSpring Biomedical Forecasted Value
In the context of forecasting VitaSpring Biomedical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. VitaSpring Biomedical's downside and upside margins for the forecasting period are 1.00 and 1.00, respectively. We have considered VitaSpring Biomedical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of VitaSpring Biomedical pink sheet data series using in forecasting. Note that when a statistical model is used to represent VitaSpring Biomedical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for VitaSpring Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as VitaSpring Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.VitaSpring Biomedical After-Hype Price Density Analysis
As far as predicting the price of VitaSpring Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VitaSpring Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of VitaSpring Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
VitaSpring Biomedical Estimiated After-Hype Price Volatility
In the context of predicting VitaSpring Biomedical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VitaSpring Biomedical's historical news coverage. VitaSpring Biomedical's after-hype downside and upside margins for the prediction period are 1.00 and 1.00, respectively. We have considered VitaSpring Biomedical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
VitaSpring Biomedical is very steady at this time. Analysis and calculation of next after-hype price of VitaSpring Biomedical is based on 3 months time horizon.
VitaSpring Biomedical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as VitaSpring Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VitaSpring Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VitaSpring Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.00 | 1.00 | 0.00 |
|
VitaSpring Biomedical Hype Timeline
VitaSpring Biomedical is at this time traded for 1.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. VitaSpring is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on VitaSpring Biomedical is about 0.0%, with the expected price after the next announcement by competition of 1.00. About 59.0% of the company outstanding shares are owned by insiders. The company had not issued any dividends in recent years. VitaSpring Biomedical had 5:1 split on the 29th of June 2020. Given the investment horizon of 90 days the next forecasted press release will be any time. Check out Historical Fundamental Analysis of VitaSpring Biomedical to cross-verify your projections.VitaSpring Biomedical Related Hype Analysis
Having access to credible news sources related to VitaSpring Biomedical's direct competition is more important than ever and may enhance your ability to predict VitaSpring Biomedical's future price movements. Getting to know how VitaSpring Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VitaSpring Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PBIGF | Paradigm Biopharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.05) | 15.38 | (13.33) | 37.57 | |
| POLBF | Poolbeg Pharma PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MSCLF | Satellos Bioscience | 0.00 | 0 per month | 3.24 | 0.21 | 10.37 | (5.77) | 22.60 | |
| KNTPF | Kintor Pharmaceutical Limited | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 27.27 | |
| AURX | Nuo Therapeutics | 0.00 | 0 per month | 0.00 | (0.06) | 7.98 | (8.26) | 34.26 | |
| IUGNF | Imugene Limited | 1.38 | 6 per month | 6.64 | 0.02 | 25.00 | (13.64) | 47.15 | |
| SPHRY | Starpharma Holdings | 0.00 | 0 per month | 2.60 | 0.1 | 8.33 | (6.25) | 33.24 | |
| GGBXF | Green Growth Brands | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SHIEF | Shield Therapeutics plc | 0.00 | 0 per month | 0.00 | 0.11 | 7.14 | 0.00 | 61.79 | |
| TOKIF | Optima Medical Innovations | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for VitaSpring Biomedical
For every potential investor in VitaSpring, whether a beginner or expert, VitaSpring Biomedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. VitaSpring Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in VitaSpring. Basic forecasting techniques help filter out the noise by identifying VitaSpring Biomedical's price trends.VitaSpring Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VitaSpring Biomedical pink sheet to make a market-neutral strategy. Peer analysis of VitaSpring Biomedical could also be used in its relative valuation, which is a method of valuing VitaSpring Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
VitaSpring Biomedical Market Strength Events
Market strength indicators help investors to evaluate how VitaSpring Biomedical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VitaSpring Biomedical shares will generate the highest return on investment. By undertsting and applying VitaSpring Biomedical pink sheet market strength indicators, traders can identify VitaSpring Biomedical Co entry and exit signals to maximize returns.
Story Coverage note for VitaSpring Biomedical
The number of cover stories for VitaSpring Biomedical depends on current market conditions and VitaSpring Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VitaSpring Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VitaSpring Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
VitaSpring Biomedical Short Properties
VitaSpring Biomedical's future price predictability will typically decrease when VitaSpring Biomedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of VitaSpring Biomedical Co often depends not only on the future outlook of the potential VitaSpring Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VitaSpring Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 206 M | |
| Cash And Short Term Investments | 107.2 K |
Other Information on Investing in VitaSpring Pink Sheet
VitaSpring Biomedical financial ratios help investors to determine whether VitaSpring Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VitaSpring with respect to the benefits of owning VitaSpring Biomedical security.